Fulgent Genetics, Inc.
Status: Publicly traded
Direct answer
Fulgent Genetics, Inc. is publicly traded on NASDAQ under the ticker FLGT.
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited...
Can you invest in Fulgent Genetics, Inc.?
Yes. Fulgent Genetics, Inc. trades publicly on NASDAQ as FLGT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fulgent Genetics, Inc.
Detailed equity research is provided by MarketSnap.